Results 171 to 180 of about 52,283 (260)

The Effect of Polycystic Ovarian Syndrome on Development of Diabetes Mellitus by a Multistate Modelling Approach. [PDF]

Endocrinol Diabetes Metab
Mousavi M, Saei Ghare Naz M, Noroozzadeh M, Azizi F, Ramezani Tehrani F.   +4 more
europepmc   +1 more source

Early‐ vs. late‐onset gestational diabetes: Differential impact on maternal and neonatal outcomes

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2012-2022, October 2026.
Early‐onset gestational diabetes mellitus (diagnosed before 20 weeks) identifies a clinically higher‐risk phenotype than late‐onset GDM (24–28 weeks), with greater insulin requirement and higher adjusted risks of preeclampsia, cesarean delivery, preterm birth, and adverse neonatal outcomes.
Baolai Li, Wenjun Ji, Rui Zhao, Jinchun Zhang   +3 more
wiley   +1 more source

Updated Overview of the Geographical Prevalence of Polycystic Ovary Syndrome by Diagnostic Criteria, Phenotypes, Race, and Ethnicity. [PDF]

Int J Environ Res Public Health
Noland MJO, Olfert MD.
europepmc   +1 more source

Digital health interventions for psychological and cognitive care in cancer patients and caregivers: A RE‐AIM‐based systematic review

Applied Psychology: Health and Well-Being, Volume 18, Issue 5, October 2026.
Abstract Beyond physical challenges, cancer can cause psychological and cognitive challenges for patients, caregivers, and family members. Digital health interventions show promise in addressing these issues. However, evidence on their applicability in daily cancer care is limited. The objective of this systematic review is to evaluate the internal and
Melissa Heifez, Laura Ciria‐Suarez, Sara Martín‐Parra, Ilaria Durosini, Dario Monzani, Veronica Coppini, Maria Vittoria Ferrari, Mareike Rutenkröger, Marie Lange, Nikolina Dodlek, Lotte van der Weijst, Andreas Charalambous, Marta Perez‐Campdepadrós, Derek Clougher, Miguel Angel Orrego, Gabriella Pravettoni, Cristian Ochoa‐Arnedo   +16 more
wiley   +1 more source

Identification of CA2 as a potential candidate gene involved in the therapeutic effect of Huatan Huoxue decoction on polycystic ovary syndrome: An integrated study of network pharmacology, Mendelian randomization, and experimental validation. [PDF]

J Food Drug Anal
Zhu C, Zhang Y, Hu P, Qi C, Chen Q, Yang H, Li J.   +6 more
europepmc   +1 more source

IMPROVE 2025: The 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence

Clinical Obesity, Volume 16, Issue 5, October 2026.
ABSTRACT An international cohort of 161 clinicians and researchers from 19 countries attended the 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE) in Prague, Czech Republic, on 2–4 July 2025. The aims of the meeting were to advance understanding of hyperphagia and obesity caused by defects in the melanocortin‐4 receptor
Jesús Argente, Erica L. T. van den Akker, Metin Cetiner, Karine Clément, Elizabeth Forsythe, Alastair Garfield, Peter Kühnen, Gabriel Ángel Martos‐Moreno, David Meeker, Hermann L. Müller, Hanneke M. van Santen, Julia von Schnurbein, Bérénice Segrestin, Tomohiro Tanaka, Manuel Tena‐Sempere, Martin Wabitsch, Stefanie Zorn, I. Sadaf Farooqi   +17 more
wiley   +1 more source

Evaluation of metabolic, reproductive, and gut microbiota alterations in a comparative study of different preclinical models of polycystic ovary syndrome. [PDF]

J Neuroendocrinol
Khobragade NH, Sheth DB, Patel CA, Beladiya JV, Patel S, Dalal M, Dholakia S.   +6 more
europepmc   +1 more source